Related Experiment Video
Updated: Jul 13, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Oxidized phospholipids in cardiovascular disease.
Sotirios Tsimikas1, Joseph L Witztum2
1Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA. stsimikas@health.ucsd.edu.
Oxidized phospholipids (OxPLs) drive chronic inflammation and atherosclerosis. Measuring OxPL-apoB in plasma improves cardiovascular risk prediction and aids therapeutic decisions, outperforming traditional markers.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Immunology
Background:
- Prolonged exposure to oxidized phospholipids (OxPLs) induces chronic inflammation, a key factor in atherosclerosis.
- OxPLs are found in atherosclerotic lesions and on apolipoprotein B (apoB)-containing lipoproteins in plasma.
- Plasma OxPL-apoB levels unexpectedly correlate strongly with lipoprotein(a) (Lp(a)) levels, not minimally oxidized LDL.
Purpose of the Study:
- To review the role of OxPLs in atherosclerosis and Lp(a) atherogenicity.
- To discuss the utility of OxPL-apoB measurement for prognosis and risk reclassification.
- To explore the impact of OxPL-apoB levels on therapeutic interventions.
Main Methods:
- Analysis of experimental and clinical studies linking OxPL-apoB, Lp(a), and cardiovascular disease.
- Evaluation of OxPL-apoB as a diagnostic and prognostic biomarker.
- Assessment of changes in OxPL-apoB levels with various lipid-lowering therapies.
Main Results:
- Lp(a) particles carry the majority of OxPLs among apoB-containing lipoproteins.
- Plasma OxPL-apoB levels offer diagnostic insights into atherosclerosis extent and improve prognostication for cardiovascular events.
- OxPL-apoB measurement enhances cardiovascular risk reclassification, especially in intermediate-risk patients.
Conclusions:
- Plasma OxPL-apoB levels predict cardiovascular events with accuracy comparable to or exceeding Lp(a) levels.
- OxPL-apoB reflects both Lp(a) genetics and lipoprotein oxidation, contributing to inflammation.
- OxPL-apoB levels are reduced by Lp(a)-lowering therapies, apheresis, niacin, and bariatric surgery.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Atherosclerosis I: Introduction
Inflammation
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...

